Skip to main content
Veterinary Medicines

Ubrolexin intramammary suspension for lactating dairy cows

Authorised
  • Cefalexin monohydrate
  • KANAMYCIN MONOSULPHATE

Identifikazzjoni tal-prodott

Isem tal-mediċina:
UBROLEXIN 20+13.3MG/G ΕΝΔΟΜΑΣΤΙΚΟ ΕΝΑΙΩΡΗΜΑ
Ubrolexin intramammary suspension for lactating dairy cows
Sustanza attiva:
Metodu ta’ amministrazzjoni:
  • Użu intramammarju

Dettalji tal-prodott

Sustanza attiva / Qawwa:
  • Disponibbli biss fi English
    210.36
    milligram(s)
    /
    1.00
    Syringe
  • Disponibbli biss fi English
    120247.00
    international unit(s)
    /
    1.00
    Syringe
Forma farmaċewtika:
  • Suspensjoni intramammarja
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        10
        day
      • Milk
        5
        day
Kodiċi veterinarju anatomiku terapewtiku kimiku (ATCvet):
  • QJ51RD01
Status tal-awtorizzazzjoni:
  • Valid
Authorised in:
  • Greece
Deskrizzjoni tal-pakkett:

Tagħrif addizzjonali

Entitlement type:
Id-detentur tal-awtorizzazzjoni għat-tqegħid fis-suq:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Siti ta’ manifattura b’rilaxx tal-lott:
  • Univet Limited
Awtorità responsabbli:
  • National Organization For Medicines
Numru tal-awtorizzazzjoni:
  • 21903/15-03-2013/K-0178601
Data tal-bidla fl-istatus tal-awtorizzazzjoni:
Numru tal-proċedura:
  • IE/V/0221/001
Stati Membri Kkonċernati:

Dokumenti

Sommarju tal-karatteristiċi tal-prodott

Dan id-dokument ma jeżistix f'dan il-lingwa (Malti). Tista 'ssibha f'lingwa oħra hawn taħt.
English (PDF)
Ippubblikat fuq: 11/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."